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differences were observed with lower amplitudes in HHb signalss for less fit
subjects. In control groups, middle aged and young subjects had significant
higher performances in VO2max, most of cognitive tests and higher ampli-
tudes changes for NIRS indices while exercising.
Conclusion: Despite comparable maximal exercise tolerances and CO,
CHD individuals presented reduced cognitive performances compared to
healthy age-matched subjects. We evidenced an inter-individual variability
among CHD patients for cerebral NIRS signals changes, especially with age
and fitness. These results suggest that variations in HHb are much more
related to exercise capacity than O2Hb in CHD patients.
261
Endothelial function in children with sickle cell disease
Khaled Hadeed (1), Yves Dulac (1), Marie Pierre Castex (2), Sebastien
Hascoet (1), Philippe Acar (1)
(1) Hôpital d’enfants, CHU Toulouse, cardiologie pédiatrique, Toulouse,
France – (2) Hôpital d’enfants, hémato-oncologie pédiatrique, Toulouse,
France
Background: Sickle cell anemia (SCA) is an inherited disorder character-
ized by recurrent painful crises with ischemia resulting from vascular occlu-
sion. Reduction of the flow mediated dilatation (FMD), secondary to impaired
release of substances such as nitric oxide, has been reported recently in adult
patient with SCA, but little is known in childrens.
Objective: (1) To describe the vascular abnormalities assessed carotid and
brachial arteries by ultrasound in a population of children with a major sickle
cell syndrome (SS). (2) To compare with controls (children of the same age
with no cardiovascular risk factor). (3) To compare vascular parameters with
clinical, biological and transcranial Doppler data.
Study population: Thirty two patients with SCA were prospectively
enrolled. Mean age was 12,3±4,5 years. Patients with SCA were closely
matched for age, gender, to 50 healthy AA subjects. Carotid IMT, cross sec-
tional compliance (CSC), distensibility (CSD) and FMD were determined
non-invasively and compared among the two groups.
Results: FMD was significantly decreased in SCA patients vs controls
(6,2±2,9 vs 8, 2±4%, p<0,05). Carotid IMT (0,45±0,03), CSC, CSD was com-
parable in SCA and controls. There was no correlation between FMD and age,
number and severity of crises, hemoglobin and LDH level, transcranial
Doppler.
Conclusions: This study demonstrated endothelial dysfunction in children
with SCA which could influence therapies in this population to prevent car-
diovascular risk factor.
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Background: While gout is considered as a risk factor for vascular dis-
eases, the relation of allopurinol with the risk of cardiovascular events is
controversial. In some studies, drug use was associated with an increased vas-
cular risk, while other studies described a protective effect.
Objectives: We conducted a case-control study to examine the relation
between allopurinol use and risk of myocardial infarction (MI).
Methods: Cases (n=2277) were successive patients with a first-ever non-
fatal MI referred to 63 cardiology centres throughout France between March
15, 2007 and November 30, 2010. They were matched to 4849 controls
selected in a large (12,313) general practice patient referent population.
Controls had no past history of coronary heart disease and were matched to
MI cases on age, gender, number of visits to a doctor in the preceding year,
date of consultation (MI) and past history of high blood pressure. Data about
medication use during the two preceding years, and past medical history and
life habits (smoking, physical activity, etc.) were obtained from patient’s stan-
dardized interview and GP records. Odds ratios (OR) and their 95% confi-
dence interval were computed using conditional logistic regression, adjusting
for classical vascular risk factors (body mass index, smoking, diabetes, phy-
sical activity).
Results: MI cases and controls had a mean age of 59 years, 76% were
men and 56% reported a history of high blood pressure. High body mass
index, low physical activity, smoking and diabetes were more prevalent in
cases than in controls. Overall, during the two preceding years, 3.8% of
controls and 3.1% of MI cases had used allopurinol, and 1.1 of both cases
and controls had used another hypouricemiant. Use of allopurinol was asso-
ciated with a non-significant decreased risk of MI (adjusted OR (95%CI):
0.75 (0.56 – 1.01).
Conclusions: This study showed that allopurinol use is not a risk factor for
first-ever non-fatal MI and might rather be associated with a decreased risk of
MI.
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Introduction: Atherosclerotic disease are a severe complications in uremic
patients. They result in particular by an increased frequency of coronary
ischemic events, responsible for 8-15% of deaths. The purpose of this study is
to evaluate the frequency and severity of atherosclerotic complications in this
population and their associations with traditional risk factors and specific
uremia.
Patients and methods: This is a multicenter cross-sectional study, only
prospective 6-months from March 2011 to August 2011, including 130 hemo-
dialysis. Complications were defined by atherosclerotic coronary artery dis-
ease, cerebrovascular disease and peripheral vascular disease. They were
classified according to severity using an index of existing co morbidities
(ICED). Comparison of patients with and without atherosclerotic complica-
tions was performed using SPSS software
Results: The frequency of atherosclerotic complications was 29.2%
(38 patients).21 patients had coronary artery disease (16.2%), 7 patients had
cerebrovascular disease (5.4%) and 16 patients had cerebrovascular disease
(12.3%). The mean age was 55.6 ± 8.96 years. We noted a male predomi-
nance. 6 patients were smokers, 30 patients had hypertension and 17 patients
were diabetic. Dyslipidemia was found in 13 patients. Coronary angiography
was performed in 13 patients showing single-vessel disease 4 patients, 2 patients
vessel disease and vessel disease in 1 patient. 5 patients had an ischemic
stroke which was a transient. 1 patient had a hemorrhagic stroke and one
patient had a carotid stenosis. 3 patients had peripheral arterial disease
confirmed and 11 patients had intermittent claudication of the lower limbs.
Atherosclerotic complications were significantly associated with age
(p=0.001), hypertension (p=0.048), systolic blood pressure (p=0.038), diabetes
(p=0.001), dyslipidemia (p=0.024) , obesity (p=0.018), triglycerides (p=0.018)
and left ventricular mass (p=0.003).
Conclusion: Uremic patients have a high incidence of atherosclerotic
disease and traditional cardiovascular risk factors.
